UnitedHealth
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 17 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.6 percentage points.
Institutional ownership
- Held by institutions
- 89.21% +0.61pp
- Institutions
- 3,917 -17
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 46 buys · 4 sells
| Name | Role | Stake |
|---|---|---|
| Stephen Hemsley | Non-Independent Non-Executive Chairperson | 0.12% |
| John Rex | Chief Financial Officer | 0.02% |
| Andrew Witty | Chief Executive Officer | 0.01% |
| Thomas Roos | Chief Accounting Officer | 0.00% |
| Wayne DeVeydt | Chief Financial Officer | 0.00% |
| Heather Cianfrocco | President of Optum | 0.00% |
| Timothy Noel | Chief Executive Officer of UnitedHealthcare Medicare & Retirement | 0.00% |
| Christopher Zaetta | Executive Vice President | 0.00% |
| Erin L. McSweeney | Executive VP & Chief People Office | 0.00% |
| Dennis Stankiewicz | Chief Accounting Officer | 0.00% |
| Frederick McNabb | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Paul Garcia | Independent Director | Other Acquisition | +103 | -- |
| 2026-09-30 | Paul Garcia | Independent Director | Other Acquisition | +155 | -- |
| 2026-09-30 | Timothy Flynn | Independent Director | Other Acquisition | +262 | -- |
| 2026-09-30 | Charles Baker | Independent Director | Other Acquisition | +257 | -- |
| 2026-09-30 | Frederick McNabb | Lead Independent Director | Other Acquisition | +291 | -- |
| 2026-09-30 | Scott Gottlieb | Independent Director | Other Acquisition | +257 | -- |
| 2026-09-30 | John Noseworthy | Independent Director | Other Acquisition | +240 | -- |
| 2026-09-30 | Valerie C. Rice | Independent Director | Other Acquisition | +257 | -- |
| 2026-09-30 | Kristen Gil | Independent Director | Other Acquisition | +240 | -- |
| 2026-09-21 | Stephen Hemsley | CEO & Non-Independent Non-Executive Chairman | Other Acquisition | +50 | -- |
| 2026-09-21 | Paul Garcia | Independent Director | Other Acquisition | +16 | -- |
| 2026-09-21 | Timothy Flynn | Independent Director | Other Acquisition | +68 | -- |
| 2026-09-21 | Charles Baker | Independent Director | Other Acquisition | +15 | -- |
| 2026-09-21 | Frederick McNabb | Lead Independent Director | Other Acquisition | +57 | -- |
| 2026-09-21 | Wayne DeVeydt | Chief Financial Officer | Other Acquisition | +106 | -- |
| 2026-09-21 | Scott Gottlieb | Independent Director | Other Acquisition | +5 | -- |
| 2026-09-21 | John Noseworthy | Independent Director | Other Acquisition | +46 | -- |
| 2026-09-21 | Valerie C. Rice | Independent Director | Other Acquisition | +47 | -- |
| 2026-09-21 | Erin L. McSweeney | Executive Vice President | Other Acquisition | +53 | -- |
| 2026-09-21 | Patrick Conway | Chief Executive Officer of Optum | Other Acquisition | +91 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-20 11:00:14 · For reference only, not investment advice and not tailored to your situation.
medical cost ratio finally stabilizing after a rough stretch, this name went from market darling to cautionary tale faster than almost anything I’ve watched in healthcare.